News

On May 23, at the European Medicines Verification Organisation’s (EMVO) General Assembly meeting, the NMVO Observers within EMVO’s Board for 2024 from the National Medicines Verification Organizations (NMVOs) were approved. Latvian Medicines Verification Organisation (LZVO) and its Chairwoman of the Board Inese Erdmane were re-elected as observers for the second consecutive year, representing the small countries group.

The European Commission has published a new version of the Questions & Answers (Q&A) document on “Safety Features for Medicinal Products for Human Use (V.21)”.

The European Medicines Verification Organisation (EMVO) has launched the EMVS Community Newsletter - edition April 2024. This month, newsletter focusing on Data Quality, featuring insights from EMVO, the Dutch NMVO, Accord Healthcare, and end-user perspectives from the healthcare sector.

While setting up the Lithuanian Medicines Verification Organization (NVVO) came with its challenges in the beginning, ever since its founding back in 2017 we have not swayed from our goal: to ensure the safety of medicines for patients.

The European Medicines Verification System, operating since 2019 in accordance with the EU Directive and Delegated Regulation, is a comprehensive, pan-European system covering all EU and EEA countries, connecting 2,800 pharmaceutical companies, 4,000 wholesalers, 110,000 pharmacies and 6,000 hospital pharmacies online, including all Latvian end users.

The system is well accepted and implemented by all end users and by the Estonian NCA. The following is a brief overview of the different ways in which packaging is checked in Estonia and the way in which alerts are managed.